Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
2025/07/04

DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. (INO) cratered 37.85% to $1.33 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.02% to 20,601.10 and the Dow Jones Industrial Average rising 0.77% to 44,828.53.

The stock's fall snapped a two-day winning streak.

Inovio Pharmaceuticals Inc. closed 89.21% below its 52-week high of $12.33, which the company reached on July 26th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.29% to $156.01, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE.AU)$ rose 0.24% to $25.38.

Trading volume (21.1 M) eclipsed its 50-day average volume of 717,459.

Data source: Dow Jones Market Data, FactSet. Data compiled July 3, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 03, 2025 17:27 ET (21:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10